ProClinical
ProClinical, a leading recruitment and staffing agency, is headquartered in Great Britain and operates across key regions including Europe, North America, and Asia. Founded in 2005, the company has established itself within the life sciences industry, specialising in the recruitment of professionals for pharmaceutical, biotechnology, and medical device sectors. ProClinical offers a range of services, including talent acquisition, executive search, and workforce solutions, distinguished by their deep industry knowledge and personalised approach. With a commitment to connecting top-tier talent with innovative companies, ProClinical has achieved significant market recognition, positioning itself as a trusted partner in the life sciences recruitment landscape. Their focus on quality and client satisfaction has led to numerous accolades, reinforcing their status as a prominent player in the industry.
DitchCarbon Score
How does ProClinical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ProClinical's score of 26 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ProClinical's reported carbon emissions
In 2023, ProClinical reported total carbon emissions of approximately 9,843,500 kg CO2e. This figure includes 251,200 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 246,700 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 9,345,600 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. Notably, business travel accounted for approximately 1,195,800 kg CO2e, while employee commuting contributed around 1,225,100 kg CO2e, and purchased goods and services were responsible for about 6,220,400 kg CO2e. In comparison, the previous year, 2022, ProClinical's total emissions were about 9,650,900 kg CO2e, with Scope 1 emissions at 372,300 kg CO2e and Scope 2 emissions at 579,300 kg CO2e. The reduction in Scope 1 and Scope 2 emissions from 2022 to 2023 indicates a shift towards more sustainable practices, although the overall increase in total emissions suggests challenges in managing Scope 3 emissions. ProClinical has not publicly committed to specific reduction targets or initiatives, which may limit their ability to effectively address their carbon footprint in the long term. As the company continues to navigate its climate commitments, a focus on reducing Scope 3 emissions will be crucial for achieving meaningful sustainability outcomes.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 372,300 | 000,000 |
| Scope 2 | 579,300 | 000,000 |
| Scope 3 | 8,699,300 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ProClinical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
